Similar Effects of the Selective Noradrenaline Reuptake Inhibitor Atomoxetine on Three Distinct Forms of Impulsivity in the Rat
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Atomoxetine is a noradrenaline-specific reuptake inhibitor used clinically for the treatment of childhood and adult attention deficit hyperactivity disorder (ADHD). Studies in human volunteers and patient groups have shown that atomoxetine improves stop-signal reaction time (SSRT) performance, an effect consistent with a reduction in motor impulsivity. However, ADHD is a heterogeneous disorder and it is of interest to determine whether atomoxetine is similarly effective against other forms of impulsivity, as well as the attentional impairment present in certain subtypes of ADHD. The present study examined the effects of atomoxetine on impulsivity using an analogous SSRT task in rats and two additional tests of impulsivity; delay discounting of reward and the five-choice serial reaction time task (5CSRTT), the latter providing an added assessment of sustained visual attention. Atomoxetine produced a significant dose-dependent speeding of SSRT. In addition, atomoxetine produced a selective, dose-dependent decrease in premature responding on the 5CSRTT. Finally, on the delay-discounting task, atomoxetine significantly decreased impulsivity by increasing preference for the large-value reward across increasing delay. These findings conclusively demonstrate that atomoxetine decreases several distinct forms of impulsivity in rats. The apparent contrast of these effects with stimulant drugs such as amphetamine and methylphenidate, which generally act to increase impulsivity on the 5CSRTT, may provide new insights into the mechanisms of action of stimulant and nonstimulant drugs in ADHD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Atomoxetine improves measures of PFC cognitive function in rats (Newman et al., 2008; Robinson et al., 2008; Seu et al., 2009), monkeys (Gamo et al., 2010; Seu et al., 2009), and humans (Chamberlain et al., 2007; Chamberlain et al., 2006).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Robinson et al., 2008
In the citing paper
“For example, atomoxetine, a relatively selective norepinephrine uptake inhibitor, improves response inhibition in both the 5-CRSTT and the stop-signal task (Robinson et al 2008).”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Robinson et al 2008
Citations
Cites
On the ability to inhibit thought and action: a theory of an act of control
Logan, G. D., & Cowan, W. B. (1984) · Psychological Review · doi:10.1037/0033-295x.91.3.295 · Cited by 2,590 · cited 1×
“Recently, atomoxetine has been shown to improve performance in normal human volunteers in a stop-signal reaction time (SSRT) task (Chamberlain et al, 2006), which provides a measure of motor inhibition and the propensity toward behavioral impulsivity (Logan and Cowan, 1984).”
BackgroundInhibitory Processes in Attention, Memory and Language
Carr, T. H., & Dagenbach, D. (1994) · Medical Entomology and Zoology · Cited by 2,362
Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans
Aron, A. R., Fletcher, P. C., Bullmore, E. T., Sahakian, B. J., & Robbins, T. W. (2003) · Nature Neuroscience · doi:10.1038/nn1003 · Cited by 1,771 · cited 2×
“…rights reserved 0893-133X/08 $30.00 www.neuropsychopharmacology.org improved, in both humans and rodents, by stimulants such as methylphenidate (Tannock et al, 1989; Aron et al, 2003b; Eagle et al, 2007b) and by the anti-narcoleptic agent modafinil (Turner et al, 2003, 2004; Eagle et al, 2007b).”
BackgroundInfluentialSelf-citationPrefrontal executive and cognitive functions in rodents: neural and neurochemical substrates
Dalley, J. W., Cardinal, R. N., & Robbins, T. W. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.09.006 · Cited by 1,329 · cited 2×
“Subjects were trained to detect the location of a brief visual stimulus (0.5 s in duration) presented pseudorandomly in one of five apertures over a large number of trials, as described previously (Dalley et al, 2004).”
MethodInfluentialSelf-citationThe 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry
Robbins, T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1154-7 · Cited by 1,282 · cited 3×
“The 5CSRTT also allows for the measurement of attentional capacity because of its requirement for rats to detect brief visual targets (Robbins, 2002).”
BackgroundMethodSelf-citationBymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123 · cited 7×
“Neuropsychopharmacology striatal DA (Bymaster et al, 2002).”
BackgroundInfluentialOn the ability to inhibit thought and action: A users' guide to the stop signal paradigm
Logan, G. D. (1994) · UvA-DARE (University of Amsterdam) · Cited by 1,115
Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions
Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.019 · Cited by 948 · cited 1×
“…with stimulant and nonstimulant medications have shown that atomoxetine, amphetamine, and methylphenidate all enhance DA and NA in the PFC (for review see Solanto, 1998; Arnsten and Li, 2005; Arnsten, 2006a, b) but atomoxetine does not increase DA in the nucleus accumbens (Bymaster et al, 2002).”
BackgroundImpulsive choice induced in rats by lesions of the nucleus accumbens core
Cardinal, R. N., Pennicott, D. R., Lakmali, C., Sugathapala, Robbins, T. W., & Everitt, B. J. (2001) · Science · doi:10.1126/science.1060818 · Cited by 923 · cited 1×
“For example, lesions of the nucleus accumbens core region impair delay discounting by enhancing impulsive choice (Cardinal et al, 2001) but have no effect on SSRT (Eagle and Robbins, 2003b).”
BackgroundSelf-citationRubia, K., Smith, A. B., Brammer, M. J., & Taylor, E. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00275-1 · Cited by 852 · cited 1×
“SSRT itself is especially susceptible to damage to the right inferior frontal cortex in humans (Aron et al, 2003a; Rubia et al, 2003), and in rats following damage to the ventral orbitofrontal cortex, but not the prelimbic or infralimbic prefrontal cortex (PFC) (Eagle and Robbins, 2003b; Eagle et…”
Background
Cited by
Inhibition and impulsivity: behavioral and neural basis of response control
Bari, A., & Robbins, T. W. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.005 · Cited by 1,921
Self-citationImpulsivity, compulsivity, and top-down cognitive control
Dalley, J. W., Everitt, B. J., & Robbins, T. W. (2011) · Neuron · doi:10.1016/j.neuron.2011.01.020 · Cited by 1,589
“…by other systems within the ventral striatum; although selective 5-HT depletion from this region fails to affect the measure (Fletcher et al., 2009), intra-accumbens 5-HT2A and 5-HT2C antagonists have opposite effects (blocking and increasing impulsivity, respectively) (Robinson et al., 2008a).”
Self-citationDrug addiction: updating actions to habits to compulsions ten years on
Everitt, B. J., & Robbins, T. W. (2016) · Annual Review of Psychology · doi:10.1146/annurev-psych-122414-033457 · Cited by 1,225
Self-citationNeurocognitive endophenotypes of impulsivity and compulsivity: Towards dimensional psychiatry
Robbins, T. W., Gillan, C. M., Smith, D. G., de Wit, S., & Ersche, K. D. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.11.009 · Cited by 1,003
Self-citationEveritt, B. J., Belin, D., Economidou, D., Pelloux, Y., Dalley, J. W., & Robbins, T. W. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0089 · Cited by 974
“This impulsivity we term ‘waiting impulsivity’, as it is related to impulsivity measured as an inability to tolerate delays of reinforcement (Robinson et al. 2008), but appears different from the response impulsivity measured by the stop-signal reaction time in STOPsignal reaction-time tasks (Eagle et al.”
MethodSelf-citationInsights into the neural basis of response inhibition from cognitive and clinical neuroscience
Chambers, C. D., Garavan, H., & Bellgrove, M. A. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.08.016 · Cited by 938
“Other dimensions of inhibitory control, including delayed discounting and premature responding, show improvement following administration of the same norepinephrine reuptake inhibitor (atomoxetine) in rats (Robinson et al., 2008).”
The role of impulsive behavior in drug abuse
Perry, J. L., & Carroll, M. E. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1173-0 · Cited by 805
“This was true of atomoxetine (Navarra et al. 2008; Robinson et al. 2007), methylphenidate (Bizarro et al.”
BackgroundMethodThe behavioral economics of substance use disorders: reinforcement pathologies and their repair
Bickel, W. K., Johnson, M. W., Koffarnus, M. N., MacKillop, J., & Murphy, J. G. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153724 · Cited by 655
“As an alternative, the nonstimulant drug atomoxetine is FDA approved for the treatment of ADHD and increases self-control in animal models (Robinson et al. 2008, Sun et al. 2012).”
BackgroundDoya, K. (2008) · Nature Neuroscience · doi:10.1038/nn2077 · Cited by 642
Fractionating impulsivity: neuropsychiatric implications
Dalley, J. W., & Robbins, T. W. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.8 · Cited by 607
“Foremost among these may be noradrenergic mechanisms; in line with this, the selective noradrenaline reuptake inhibitor atomoxetine has striking anti-impulsivity effects in all major impulsivity tests in rodents (including premature responding tests, delay discounting tasks and SSRT task) 89 .”
Self-citationEagle, D. M., Bari, A., & Robbins, T. W. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1127-6 · Cited by 548
Self-citationAron, A. R., Durston, S., Eagle, D. M., Logan, G. D., Stinear, C. M., & Stuphorn, V. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3644-07.2007 · Cited by 539
Self-citationDopamine, serotonin and impulsivity
Dalley, J. W., & Roiser, J. P. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.065 · Cited by 501
“2B) (Dahlstroem and Fuxe, 1964; Azmitia and Segal, 1978) and make extensive connections with a number of structures involved in the regulation of impulse control, principally the ventral tegmental area (VTA), substantia nigra (SNc), nucleus accumbens (NAcb), hippocampus, amygdala , and prefrontal cortex (Dalley et al.…”
InfluentialSelf-citationThe neuropharmacology of impulsive behaviour
PATTIJ, T., & VANDERSCHUREN, L. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.01.002 · Cited by 473
Logue, S. F., & Gould, T. J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.08.007 · Cited by 477
“In rats, increasing synaptic levels of NE with atomoxetine improved inhibitory response control (Bari et al. 2009; Robinson et al. 2008) without altering reaction time on correctly initiated responses (Robinson et al. 2008).”
BackgroundNeurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry
Dalley, J. W., Mar, A. C., Economidou, D., & Robbins, T. W. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.12.021 · Cited by 467
Self-citationBari, A., Dalley, J. W., & Robbins, T. W. (2008) · Nature Protocols · doi:10.1038/nprot.2008.41 · Cited by 452
Self-citationArnsten, A. F. T., & Pliszka, S. R. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.020 · Cited by 383
“Atomoxetine improves measures of PFC cognitive function in rats (Newman et al., 2008; Robinson et al., 2008; Seu et al., 2009), monkeys (Gamo et al.”
BackgroundRemoving Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models
Markou, A., Chiamulera, C., Geyer, M. A., Tricklebank, M., & Steckler, T. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.173 · Cited by 328
“Similarly, the response of rats to atomoxetine in the stop signal reaction time test of impulsivity is much greater in slow compared with fast responders (Robinson et al, 2008).”
The neurobiology of impulsivity and substance use disorders: implications for treatment
Kozak, K., Lucatch, A. M., Lowe, D. J. E., Balodis, I. M., MacKillop, J., & George, T. P. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13977 · Cited by 281
Chamberlain, S. R., Hampshire, A., Müller, U., Rubia, K., del Campo, N., Craig, K., Regenthal, R., Suckling, J., Roiser, J. P., Grant, J. E., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.014 · Cited by 301
Self-citationYoung, J. W., Powell, S. B., Risbrough, V., Marston, H. M., & Geyer, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.004 · Cited by 298
Eagle, D. M., & Baunez, C. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.003 · Cited by 280
“This receptor-subtype specificity may be peculiar to premature response control, since neither 5-HT2A nor 5-HT2C drugs affected perseverative responding in normal and 5-HT-lesioned rats on this task (Robinson et al., 2008).”
InfluentialSelf-citationNucleus accumbens and impulsivity
Basar, K., Sesia, T., Groenewegen, H., Steinbusch, H. W. M., Visser-Vandewalle, V., & Temel, Y. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.08.007 · Cited by 280
“Atomoxetine, a selective noradrenaline reuptake inhibitor, was reported to decrease diverse features of impulsivity assessed by different tasks in rats, such as the SSRT, 5CSRT tests and delay discounting task (Robinson et al., 2008).”
Dissecting impulsivity and its relationships to drug addictions
Jentsch, J. D., Ashenhurst, J. R., Cervantes, M. C., Groman, S. M., James, A. S., & Pennington, Z. T. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12388 · Cited by 281
The Relationship between Impulsive Choice and Impulsive Action: A Cross-Species Translational Study
Broos, N., Schmaal, L., Wiskerke, J., Kostelijk, L., Lam, T., Stoop, N., Weierink, L., Ham, J., de Geus, E. J. C., Schoffelmeer, A. N. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036781 · Cited by 228
“Surprisingly, in contrast to earlier work showing a decrease [41] or null effects [42] of atomoxetine on impulsive choice, in the current study, we found that atomoxetine modestly, but significantly, increased impulsive choice.”
ResultStrickland, J. C., & Johnson, M. W. (2021) · Psychological Review · doi:10.1037/rev0000263 · Cited by 222
“Relevant, however, is another study in male rats that found that atomoxetine could produce dose-dependent decreases in impulsivity across three separate experimental tasks (i.e., stop-signal reaction time, 5-CSRTT, and delay discounting; Robinson et al., 2008).”
BackgroundHigh Impulsivity Predicts Relapse to Cocaine-Seeking After Punishment-Induced Abstinence
Economidou, D., Pelloux, Y., Robbins, T. W., Dalley, J. W., & Everitt, B. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.008 · Cited by 233
Self-citationMolecular psychiatry of zebrafish
Stewart, A. M., Ullmann, J. F. P., Norton, W. H. J., Parker, M. O., Brennan, C. H., Gerlai, R., & Kalueff, A. V. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.128 · Cited by 228
Winstanley, C. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01323.x · Cited by 218
“…on different tests of impulsivity in the rat Drug 5CSRT SST Go/no-go Delay discounting Study ↑ – ↓ Study ↑ –↓ Study ↑ – ↓ Study ↑ – ↓ Atomoxetine Robinson et al., 2008 Navarra et al., 2008b Tsutsui-Kimura et al., 2009 Blondeau and Dellu-Hagedorn, 2007 ↓ Robinson et al., 2008 Bari et al., 2009 ↓ ???”
BackgroundInfluentialAnimal Models of Neuropsychiatric Disorders
Fernando, A. B. P., & Robbins, T. W. (2011) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032210-104454 · Cited by 211
Self-citationNoradrenergic modulation of cognition: Therapeutic implications
Chamberlain, S. R., & Robbins, T. W. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113480988 · Cited by 190
“Worth noting is that atomoxetine has been found likewise to reduce impulsive/premature responses on the aforeconsidered 5-CRT paradigm (Robinson, 2012; Robinson et al., 2008).”
BackgroundSelf-citationNeurotransmitter deficits from frontotemporal lobar degeneration
Murley, A. G., & Rowe, J. B. (2018) · Brain · doi:10.1093/brain/awx327 · Cited by 202
“Reprinted with permission from Springer. models, for example rats, limiting noradrenergic transmission results in impaired executive function (Newman et al. , 2008; Chandler et al. , 2014) and increasing noradrenaline levels reduces impulsivity (Robinson et al. , 2008).”
Oades, R. D., Lasky-Su, J., Christiansen, H., Faraone, S. V., Sonuga-Barke, E. J. S., Banaschewski, T., Chen, W., Anney, R. J. L., Buitelaar, J. K., Ebstein, R. P., et al. (2008) · Behavioral and Brain Functions · doi:10.1186/1744-9081-4-48 · Cited by 200
“More differentiated views of impulsiveness [20] suggest that, as well as aggressive and behavioral impulsiveness associated with emotional lability and motor control, there are also cognitive or attention-related elements [21]; for example, there are the cognitive expressions of impulsiveness that are associated with…”
Bari, A., Eagle, D. M., Mar, A. C., Robinson, E. S. J., & Robbins, T. W. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1537-0 · Cited by 194
“We have replicated recent findings of speeding effects of the SNRI atomoxetine on the SSRT measure of behavioral inhibition in humans (Chamberlain et al. 2006) and rats (Robinson et al. 2008).”
InfluentialSelf-citationAnterior Cingulate Cortex Input to the Claustrum Is Required for Top-Down Action Control
White, M. G., Panicker, M., Mu, C., Carter, A. M., Roberts, B. M., Dharmasri, P. A., & Mathur, B. N. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.023 · Cited by 183
“Thus, poke accuracy is consistent with the operational definition of attention from past reports (Muir et al., 1996; Passetti et al., 2002; Dalley et al., 2004; Robinson et al., 2008).”
BackgroundMethodResultInfluentialThe 5-Choice Continuous Performance Test: Evidence for a Translational Test of Vigilance for Mice
Young, J. W., Light, G. A., Marston, H. M., Sharp, R., & Geyer, M. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004227 · Cited by 184
“demonstrated that multiple aspects can be differentiated in animal studies [66].”
BackgroundPrefrontal and monoaminergic contributions to stop-signal task performance in rats
Bari, A., Mar, A. C., Theobald, D. E., Elands, S. A., Oganya, K. C. N. A., Eagle, D. M., & Robbins, T. W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1543-11.2011 · Cited by 188
Self-citationGroman, S. M., James, A. S., & Jentsch, J. D. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.08.008 · Cited by 177
“On the other hand, atomoxetine, a selective norepinephrine reuptake inhibitor, appears to consistently improve response inhibition in a variety of preclinical measures (Robinson et al. 2007; Seu et al. 2008).”
BackgroundRobinson, E. S. J., Eagle, D. M., Economidou, D., Theobald, D. E. H., Mar, A. C., Murphy, E. R., Robbins, T. W., & Dalley, J. W. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.09.021 · Cited by 178
Self-citationDimensions of impulsive behavior in adolescents: Laboratory behavioral assessments.
Reynolds, B., Penfold, R. B., & Patak, M. (2008) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.16.2.124 · Cited by 167
Perry, J. L., Joseph, J. E., Jiang, Y., Zimmerman, R. S., Kelly, T. H., Darna, M., Huettl, P., Dwoskin, L. P., & Bardo, M. T. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.09.001 · Cited by 180
Chamberlain, S. R., Robbins, T. W., Winder-Rhodes, S., Müller, U., Sahakian, B. J., Blackwell, A. D., & Barnett, J. H. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.019 · Cited by 178
Self-citationPrefrontal cortex executive processes affected by stress in health and disease
Girotti, M., Adler, S. M., Bulin, S. E., Fucich, E. A., Paredes, D., & Morilak, D. A. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.004 · Cited by 176
The Molecular Genetics of Executive Function: Role of Monoamine System Genes
Barnes, J. J. M., Dean, A. J., Nandam, L. S., O'Connell, R. G., & Bellgrove, M. A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.040 · Cited by 164
“for effect of atomoxetine on SSRT in rodents (104).”
BackgroundDissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats
Baarendse, P. J. J., & Vanderschuren, L. J. M. J. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2576-x · Cited by 167
“In contrast, Robinson et al. (2008) reported that atomoxetine reduced impulsive choice whereby the increase in percentage choice for the large reward after atomoxetine treatment was most pronounced at the shorter delays.”
InfluentialHosking, J. G., Floresco, S., & Winstanley, C. A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.285 · Cited by 185
“…the 5-choice serial reaction-time task (5CSRTT), no change in premature responding was observed on the rCET following administration of either noradrenergic compound, despite the similarities in trial structure between the two tasks (Navarra et al, 2008; Robinson et al, 2008; Sun et al, 2010).”
ResultSerotonin and decision making processes
Homberg, J. R. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.06.001 · Cited by 167
Eagle, D. M., Lehmann, O., Theobald, D. E. H., Peña‐Oliver, Y., Zakaria, R., Ghosh, R., Dalley, J. W., & Robbins, T. W. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.202 · Cited by 170
“…speed at which the inhibitory process occurs in the first instance is not influenced by 5-HT mechanisms, in marked contrast with other data from both humans and rats showing significant effects of a selective NA-receptor blocker, atomoxetine, on SSRT (Chamberlain et al, 2006; Robinson et al, 2008).”
ResultSelf-citationEffects of chronic stress on cognitive function – From neurobiology to intervention
Girotti, M., Bulin, S. E., & Carreno, F. R. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100670 · Cited by 209
“Pharmacological increases in extracellular norepinephrine levels by norepinephrine transporter (NET) blockers, such as atomoxetine, consistently increase preference for larger delayed rewards in delay discounting tasks (Robinson et al., 2008b; Sun et al., 2012).”
Cognitive enhancement as a pharmacotherapy target for stimulant addiction
Sofuoglu, M. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02791.x · Cited by 161
“In pre-clinical studies, atomoxetine improved performance in various forms of impulsivity [100] and attention in rats [101] as well as reversal learning in rats and monkeys [102].”
BackgroundVoon, V., Irvine, M. A., Derbyshire, K., Worbe, Y., Lange, I., Abbott, S., Morein-Zamir, S., Dudley, R., Caprioli, D., Harrison, N. A., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.013 · Cited by 152
“Atomoxetine, a selective norepinephrine-reuptake inhibitor also dose-dependently decreases premature responding (31).”
BackgroundSelf-citationRobinson, E. S. J., Dalley, J. W., Theobald, D. E. H., Glennon, J. C., Pezze, M. A., Murphy, E. R., & Robbins, T. W. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301636 · Cited by 166
“…to a growing body of evidence for an involvement of multiple neurotransmitter systems in the mediation and control of impulsive behavior, including in addition to 5-HT and DA, the noradrenergic (Robinson et al, 2007; Blondeau and Dellu-Hagedorn, 2007) and histaminergic (Day et al, 2007) systems.”
Self-citationTargeting impulsivity in Parkinson’s disease using atomoxetine
Kehagia, A. A., Housden, C. R., Regenthal, R., Barker, R. A., Müller, U., Rowe, J., Sahakian, B. J., & Robbins, T. W. (2014) · Brain · doi:10.1093/brain/awu117 · Cited by 139
“In the rat, atomoxetine has been shown to enhance inhibition on the stop signal task, as well as the fivechoice serial reaction time and delay discounting tasks (Robinson et al., 2008).”
Self-citationImpulsive choice and environmental enrichment: Effects of d-amphetamine and methylphenidate
Perry, J. L., Stairs, D. J., & Bardo, M. T. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.04.019 · Cited by 157
Reward, interrupted: Inhibitory control and its relevance to addictions
Jentsch, J. D., & Pennington, Z. T. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.022 · Cited by 134
“medicines that reliably improve inhibitory control (Bari et al., 2009; Brigman et al., 2010; Floresco and Jentsch, 2011; Robinson et al., 2008; Seu and Jentsch, 2009; Seu et al., 2009) and potentially effectively suppress drug-taking behaviors is just beginning, and the value of already proposed molecules (e.”
BackgroundComparative study of the effects of bupropion and escitalopram onInternet gaming disorder
Song, J., Park, J. H., Han, D. H., Roh, S., Son, J. H., Choi, T. Y., Lee, H., Kim, T. H., & Lee, Y. S. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12429 · Cited by 135
“Enhancing norepinephrine level through systemic treatment with atomoxetine, a selective norepinephrine reuptake transporter inhibitor, decreases several distinct forms of impulsivity.(31,32) By increasing Table 2.”
BackgroundMarsh, L., Biglan, K., Gerstenhaber, M., & Williams, J. R. (2009) · Movement Disorders · doi:10.1002/mds.22307 · Cited by 135
Multiple Modes of Impulsivity in Parkinson's Disease
Nombela, C., Rittman, T., Robbins, T. W., & Rowe, J. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085747 · Cited by 134
“These neurochemical dissociations are retained in the context of developmental and psychiatric disease [11,18–21].”
BackgroundSelf-citationTranslating cognition from animals to humans
Keeler, J. F., & Robbins, T. W. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.028 · Cited by 137
Self-citationNewman, L. A., Darling, J., & McGaughy, J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1097-8 · Cited by 137
Behavioural and physiological correlates of impulsivity in the domestic dog (Canis familiaris)
Wright, H. F., Mills, D. S., & Pollux, P. M. J. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.09.019 · Cited by 155
“5 noradrenergic systems in impulsivity [41],[42].”
Fernando, A. B. P., Economidou, D., Theobald, D. E., Zou, M.-F., Newman, A. H., Spoelder, M., Caprioli, D., Moreno, M., Hipόlito, L., Aspinall, A. T., et al. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2408-z · Cited by 135
“2008), stop-signal reaction time task and the delay discounting paradigm (Robinson et al. 2008).”
MethodSelf-citationEconomidou, D., Theobald, D. E., Robbins, T. W., Everitt, B. J., & Dalley, J. W. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.53 · Cited by 131
“Thus, intra-NAcbS infusions of ATO resulted in a marked reduction in impulsivity of a magnitude similar to the effects of systemically administering ATO (Paterson et al, 2011; Robinson et al, 2008).”
BackgroundResultSelf-citationParker, M. O., Brock, A. J., Walton, R. T., & Brennan, C. H. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00063 · Cited by 149
“In addition, systemic atomoxetine, a noradrenergic reuptake inhibitor, reduces impulsivity (Robinson et al., 2008).”
BackgroundInhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys
Seu, E., Lang, A., Rivera, R. J., & Jentsch, J. D. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1250-4 · Cited by 121
“…membrane transporter improve multiple aspects of inhibitory control over responding (Blondeau and Dellu-Hagedorn 2007; Chamberlain et al. 2007; Lapiz et al. 2007; Navarra et al. 2008; Robinson et al. 2008) underscore their potential in regards to the treatment of these behavioral disorders.”
BackgroundResultInfluentialTrichotillomania: neurobiology and treatment
Chamberlain, S. R., Odlaug, B. L., Boulougouris, V., Fineberg, N. A., & Grant, J. E. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.02.002 · Cited by 126
“Response inhibition as a cognitive function is dependent on neural circuitry including the right inferior frontal gyrus, and is affected by manipulations of the noradrenaline system, but not of the serotonin system, in humans and rats (Chamberlain et al., 2006c,d,e, 2007a; Aron et al., 2007; Eagle et al., 2007; Robins…”
BackgroundPharmacological Enhancement of Memory and Executive Functioning in Laboratory Animals
Floresco, S., & Jentsch, J. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.158 · Cited by 129
Loos, M., Pattij, T., Janssen, M. C. W., Counotte, D. S., Schoffelmeer, A. N. M., Smit, A. B., Spijker, S., & van Gaalen, M. M. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhp167 · Cited by 109
“Manipulation of dopamine, noradrenalin, and serotonin neurotransmission is known to modulate impulsive choice (Winstanley et al. 2005; van Gaalen et al. 2006; Robinson et al. 2008; for review, see Pattij and Vanderschuren 2008).”
BackgroundImproving Response Inhibition in Parkinson’s Disease with Atomoxetine
Ye, Z., Altena, E., Nombela, C., Housden, C. R., Maxwell, H., Rittman, T., Huddleston, C., Rae, C. L., Regenthal, R., Sahakian, B. J., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.024 · Cited by 105
Self-citationBari, A., Xu, S., Pignatelli, M., Takeuchi, D., Feng, J., Li, Y., & Tonegawa, S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2015635117 · Cited by 121
Self-citationBaarendse, P. J. J., Winstanley, C. A., & Vanderschuren, L. J. M. J. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2857-z · Cited by 111
“…when task performance is suboptimal due to demanding task conditions or inherent high baseline levels of impulsive action (Baarendse and Vanderschuren 2012; Blondeau and Dellu-Hagedorn 2007; Fernando et al. 2012; Navarra et al. 2008; Paine et al. 2007; Paterson et al. 2011; Robinson et al. 2008).”
Developing treatments for cognitive deficits in schizophrenia: The challenge of translation
Young, J., & Geyer, M. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114555252 · Cited by 110
“Given that atomoxetine also reduced false alarm responding and premature responding (Robinson et al., 2008), this mechanism (norepinephrine transporter inhibition) likely affects non-specific inhibitory processes.”
BackgroundBari, A., & Robbins, T. W. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3141-6 · Cited by 105
“The positive effects of atomoxetine (Robinson et al. 2008) and atipamezole (present experiment) on SST performance, point to a beneficial role of increasing NA neurotransmission in forebrain areas, although achieved by different mechanisms.”
BackgroundSelf-citationMethylphenidate Disrupts Social Play Behavior in Adolescent Rats
Vanderschuren, L. J. M. J., Trezza, V., Griffioen-Roose, S., Schiepers, O. J. G., Van Leeuwen, N., De Vries, T. J., & Schoffelmeer, A. N. M. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.10 · Cited by 105
Acute effects of morphine on distinct forms of impulsive behavior in rats
Pattij, T., Schetters, D., Janssen, M. C. W., Wiskerke, J., & Schoffelmeer, A. N. M. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1558-8 · Cited by 105
“…noradrenaline transmission by the selective noradrenaline reuptake inhibitor atomoxetine reduces impulsivity in the delayed reward paradigm (Robinson et al. 2008), a finding that is possibly explained by the effects of atomoxetine on cortical noradrenaline transmission (Bymaster et al.…”
BackgroundFletcher, P. J., Rizos, Z., Noble, K., & Higgins, G. A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.025 · Cited by 109
“…effects of serotonin acting via 5-HT2A and 5-HT2C receptors in the expression of impulsive behaviour (Fletcher et al., 2007; Higgins et al., 2003; Robinson et al., 2008a; Winstanley et al., 2004b), and behaviours which may result from impaired impulse control, such as drug seeking behaviour…”
Broos, N., Diergaarde, L., Schoffelmeer, A. N. M., Pattij, T., & Vries, T. J. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.323 · Cited by 108
“…effects of the clinically used norepinephrine transporter inhibitor atomoxetine on impulsivity (Blondeau and Dellu-Hagedorn, 2007; Chamberlain et al, 2007; Paterson et al, 2011; Robinson et al, 2008) and drug taking or seeking (Economidou et al, 2011; Wilens et al, 2008), supporting this notion.”
BackgroundThe Mouse Claustrum Is Required for Optimal Behavioral Performance Under High Cognitive Demand
White, M. G., Mu, C., Qadir, H., Madden, M. B., Zeng, H., & Mathur, B. N. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.03.020 · Cited by 106
O’Callaghan, C., Hezemans, F. H., Ye, R., Rua, C., Jones, P. S., Murley, A. G., Holland, N., Regenthal, R., Tsvetanov, K. A., Wolpe, N., et al. (2021) · Brain · doi:10.1093/brain/awab142 · Cited by 109
Self-citationThe role of impulsivity in relapse vulnerability
Pattij, T., & Vries, T. J. D. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.01.023 · Cited by 103
“By contrast, reducing impulsive action with, for instance, the dopamine D1 receptor antagonist SCH-23390 [47], the serotonin2A receptor antagonist M100907 [48] and the clinically prescribed noradrenaline reuptake inhibitor atomoxetine [43] does match the directionality of their effects on reinstatement of cocaine seek…”
BackgroundResultSex Differences in Behavioral Dyscontrol: Role in Drug Addiction and Novel Treatments
Carroll, M. E., & Smethells, J. R. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00175 · Cited by 98
“Laboratory Animals The relationship between ATO and impulsive behavior has been shown using several behavioral tasks in animals, such as the 5-CSRTT (76, 241), the SSRT task (76), and delay discounting (76, 235), but in other studies, ATO did not modify impulsivity (70, 241).”
MethodCross‐species studies of cognition relevant to drug discovery: a translational approach
Robbins, T. W. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13826 · Cited by 97
“Using the SSRT paradigm devised by Eagle and Robbins (2003), Robinson et al. (2008) showed that the drug produced dose-dependent improvements in SSRT performance whilst not affecting parameters of performance such as the Go reaction time in rats.”
MethodSelf-citationEpigenetics in Developmental Disorder: ADHD and Endophenotypes
Archer, T., & Oscar Berman, M. (2011) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.1000104 · Cited by 92
“Failure of executive inhibitory functioning is linked to the emotional lability and dysfunctional motor control expressed in impulsive aggressiveness [206-209], often displayed in maladaptive responding and misappropriate actions of ADHD individuals [210-212].”
BackgroundSetlow, B., Mendez, I. A., Mitchell, M. R., & Simon, N. W. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283305eb4 · Cited by 92
“targeting other neurotransmitter systems (e.g. atomoxetine targeting the norepinephrine transporter; Robinson et al., 2007) are effective in cocaine-exposed subjects, but”
BackgroundRogers, R. D., Moeller, F. G., Swann, A. C., & Clark, L. (2010) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01216.x · Cited by 87
“, 2005a) are convergent with the results of pharmacological challenges in rats, demonstrating improvements in action cancellation following atomoxetine (Robinson et al., 2008).”
ResultGau, S. S.-F., & Shang, C.-Y. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990836 · Cited by 91
“2006, 2007), atomoxetine was associated with decreased probability of false alarms and increased strength of trace required to elicit a response, consistent with its efficacy in reducing impulsivity (Robinson et al. 2008) and improving inhibitory controls (Barton et al.”
BackgroundResultObeso, I., Wilkinson, L., & Jahanshahi, M. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2793-x · Cited by 94
“…improve/speed up SSRT (i.e. to reduce impulsivity during the stop-signal RT task) in healthy participants (Chamberlain et al. 2006) and in adults with ADHD (Chamberlain et al. 2007), and to improve SSRT in a dose-dependent fashion in rats without aVecting the speed of Go RTs (Robinson et al. 2008).”
BackgroundSun, H., Cocker, P. J., Zeeb, F. D., & Winstanley, C. A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2419-9 · Cited by 95
“Similarly, the fact that atomoxetine decreased premature responding is likewise in accordance with previously published data (Navarra et al. 2008; Robinson et al. 2008; Tsutsui-Kimura et al. 2009).”
InfluentialPaterson, N. E., Ricciardi, J., Wetzler, C., & Hanania, T. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.10.001 · Cited by 90
Bari, A., & Aston-Jones, G. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.020 · Cited by 85
“ATM improves indices of prefrontal executive functions such as working memory (Gamo et al., 2010; Tzavara et al., 2006), inhibition (Chamberlain et al., 2006; Robinson et al., 2008) and attention (Jentsch et al., 2009) in normal subjects also.”
BackgroundInfluentialSelf-citationCurrent animal models of obsessive compulsive disorder: an update.
Albelda, N., & Joel, D. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.070 · Cited by 85
“The finding that administration of the SNRI atomoxetine to male rats did not affect perseveration in this task (Robinson et al., 2008), is encouraging, yet further studies assessing the effects of S/SRIs as well as of additional drugs that are inefficient in OCD are crucial for establishing the predictive validity of…”
BackgroundTherapeutic Potential of 5-HT2CReceptor Agonists for Addictive Disorders
Higgins, G. A., & Fletcher, P. J. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00025 · Cited by 83
Translational approaches to obsessive‐compulsive disorder: from animal models to clinical treatment
Fineberg, N., Chamberlain, Sr., Hollander, E., Boulougouris, V, & Robbins, T. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01422.x · Cited by 82
Self-citationRobinson, E. S. J. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2420-3 · Cited by 87
Self-citationValue-free random exploration is linked to impulsivity
Dubois, M., & Hauser, T. U. (2022) · Nature Communications · doi:10.1038/s41467-022-31918-9 · Cited by 68
“Impulsivity has been linked to imbalances in catecholamine functioning 7 – 13 but how these imbalances affect behaviour remains unknown.”
BackgroundPaterson, N. E., Wetzler, C., Hackett, A., & Hanania, T. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001635 · Cited by 74
“It should be noted that the effects of atomoxetine in Robinson et al. (2008) were limited to a single intermediate dose (1.0 mg/kg) following a simple main effect of dose.”
BackgroundMethodResultInfluentialReducing substance use during adolescence: a translational framework for prevention
Stanis, J. J., & Andersen, S. L. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3393-1 · Cited by 70
“Impulsive action, or impairment in the ability to inhibit a pre-potent motor response, is measured by the stop signal reaction time test (Robinson et al. 2008; Eagle et al. 2008; Fineberg et al. 2010).”
BackgroundMethodTargeting cocaine versus heroin memories: divergent roles within ventromedial prefrontal cortex
Peters, J., Pattij, T., & Vries, T. J. D. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.10.004 · Cited by 78
Ye, Z., Rae, C. L., Nombela, C., Ham, T., Rittman, T., Jones, P. S., Rodríguez, P. V., Coyle‐Gilchrist, I., Regenthal, R., Altena, E., et al. (2016) · Human Brain Mapping · doi:10.1002/hbm.23087 · Cited by 68
“However, the behavioral effects of atomoxetine and citalopram depend on individual differences in the baseline state of noradrenergic and serotonergic systems [Robinson et al., 2008; Ye et al., 2014, 2015] which may be one reason why unstratified studies yield negative results.”
BackgroundSelf-citation
Metadata
- Authors
- Robinson, E. S. J., Eagle, D. M., Mar, A. C., Bari, A., Banerjee, G., Jiang, X., Dalley, J. W., & Robbins, T. W.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Eagle, Dawn M
- ORCID
- Venue
- Neuropsychopharmacology
- Published
- 2007-07-18
- Volume
- 33
- Issue
- 5
- Pages
- 1028-1037
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1992488100
- Cited by
- 359
- References
- 66
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 16 · 2023: 11 · 2022: 15 · 2021: 17 · 2020: 13 · 2019: 10 · 2018: 18 · 2017: 21 · 2016: 21 · 2015: 20 · 2014: 37 · 2013: 23 · 2012: 25
- FWCI
- 12.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Explore Bristol Research (submittedVersion)
- Funders
- Wellcome Trust
- British Pharmacological Society
- Research Councils UK
- Medical Research Council
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- atomoxetine, impulsivity, attention deficit hyperactivity disorder, norepinephrine reuptake inhibition, stop-signal reaction time, delay discounting, 5-choice serial reaction time task, visual attention, stimulants, amphetamine, methylphenidate, rats
- MeSH terms
- Atomoxetine Hydrochloride, Analysis of Variance, Animals, Behavior, Animal, Choice Behavior, Dose-Response Relationship, Drug, Impulsive Behavior, Inhibition, Psychological, Male, Propylamines, Reaction Time, Reinforcement, Psychology, Reinforcement Schedule, Task Performance and Analysis, Adrenergic Uptake Inhibitors, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.